Thank you for your interest in Mirum Pharmaceuticals (“Mirum”). We value our relationship with you and want to ensure our lines of communication remain open. The use of your Personal Data for electronic communications by Mirum requires your explicit consent. Your consent will enable us to communicate with you via e-mail and allow us to send you the occasional newsletter, articles of interest, invitations and other promotional or non-promotional communications in the area of cholestatic liver disease. We will do our best to ensure our communications will be relevant to your area of expertise and keep the frequency at a very reasonable level. If you don’t like what you see, please speak with us, we are always happy to receive direct feedback from our customers.

To receive these electronic communications from Mirum, please fill out the form below:

By selecting “SUBMIT” you consent to receive
e-mail communications from Mirum*,
including promotional and non-promotional information as mentioned above and according to the privacy notice.